Fintel on MSN6 小时
Wolfe Research Initiates Coverage of Moderna (MRNA) with Underperform Recommendation
Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Moderna (NasdaqGS:MRNA) with a Underperform ...
Fintel on MSN13 小时
Wolfe Research Initiates Coverage of Bristol-Myers Squibb (BMY) with Peer Perform ...
Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Bristol-Myers Squibb (NYSE:BMY) with a Peer ...
bovnews14 小时
Wolfe Research Issues Peer Perform Rating for Warner Bros Discovery Inc (WBD) Stock
Wolfe Research has recently raised Warner Bros Discovery Inc (WBD) stock to Peer Perform rating, as announced on November 11, 2024, according to Finviz. Earlier, on August 13, 2024, Bernstein had ...
Wolfe Research为Veracyte设定股票目标价，看好其增长潜力
周五，Wolfe Research对诊断公司Veracyte, Inc (NASDAQ:VCYT)的股票进行了首次评级，给予"优于大市"评级，目标价为$50.00。该研究机构强调了Veracyte自2021年以来显著的收入增长和毛利率扩张。据该研究机构称，Veracyte的收入已翻倍，毛利率提高了约500个基点。 该公司有望在本年度实现9000万至1亿美元的调整后EBITDA。Wolfe Rese ...